206 related articles for article (PubMed ID: 32647130)
21. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
22. Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.
Sorrentino ZA; Xia Y; Gorion KM; Hass E; Giasson BI
FEBS Lett; 2020 Apr; 594(8):1271-1283. PubMed ID: 31912891
[TBL] [Abstract][Full Text] [Related]
23. Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma.
Evans SR; West C; Klein-Seetharaman J
Comput Struct Biotechnol J; 2021; 19():5348-5359. PubMed ID: 34667532
[TBL] [Abstract][Full Text] [Related]
24. Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo.
Thom T; Schmitz M; Fischer AL; Correia A; Correia S; Llorens F; Pique AV; Möbius W; Domingues R; Zafar S; Stoops E; Silva CJ; Fischer A; Outeiro TF; Zerr I
Mov Disord; 2022 Jan; 37(1):39-51. PubMed ID: 34448510
[TBL] [Abstract][Full Text] [Related]
25. Dynamic Properties of Human α-Synuclein Related to Propensity to Amyloid Fibril Formation.
Fujiwara S; Kono F; Matsuo T; Sugimoto Y; Matsumoto T; Narita A; Shibata K
J Mol Biol; 2019 Aug; 431(17):3229-3245. PubMed ID: 31181290
[TBL] [Abstract][Full Text] [Related]
26. Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces.
Rovere M; Sanderson JB; Fonseca-Ornelas L; Patel DS; Bartels T
FEBS Lett; 2018 May; 592(9):1464-1472. PubMed ID: 29633780
[TBL] [Abstract][Full Text] [Related]
27. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
Watson MD; Lee JC
Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
[TBL] [Abstract][Full Text] [Related]
28. Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion.
Agarwal A; Arora L; Rai SK; Avni A; Mukhopadhyay S
Nat Commun; 2022 Mar; 13(1):1154. PubMed ID: 35241680
[TBL] [Abstract][Full Text] [Related]
29. Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers.
Purro SA; Nicoll AJ; Collinge J
Biol Psychiatry; 2018 Feb; 83(4):358-368. PubMed ID: 29331212
[TBL] [Abstract][Full Text] [Related]
30. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
[TBL] [Abstract][Full Text] [Related]
31. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
32. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
33. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
Scialò C; Legname G
Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of Strain Diversity of Disease-Associated in-Register Parallel β-Sheet Amyloids and Implications About Prion Strains.
Taguchi Y; Otaki H; Nishida N
Viruses; 2019 Jan; 11(2):. PubMed ID: 30696005
[TBL] [Abstract][Full Text] [Related]
35. Measuring Mitochondrial Dysfunction Caused by Soluble α-Synuclein Oligomers.
Luth ES; Stavrovskaya IG
Methods Mol Biol; 2019; 1948():183-198. PubMed ID: 30771178
[TBL] [Abstract][Full Text] [Related]
36. Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.
Fujiwara S; Araki K; Matsuo T; Yagi H; Yamada T; Shibata K; Mochizuki H
PLoS One; 2016; 11(4):e0151447. PubMed ID: 27097022
[TBL] [Abstract][Full Text] [Related]
37. Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.
Tóth G; Neumann T; Berthet A; Masliah E; Spencer B; Tao J; Jobling MF; Gardai SJ; Bertoncini CW; Cremades N; Bova M; Ballaron S; Chen XH; Mao W; Nguyen P; Tabios MC; Tambe MA; Rochet JC; Junker HD; Schwizer D; Sekul R; Ott I; Anderson JP; Szoke B; Hoffman W; Christodoulou J; Yednock T; Agard DA; Schenk D; McConlogue L
Sci Rep; 2019 Nov; 9(1):16947. PubMed ID: 31740740
[TBL] [Abstract][Full Text] [Related]
38. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
39. Implications of Metal Binding and Asparagine Deamidation for Amyloid Formation.
Sadakane Y; Kawahara M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126231
[TBL] [Abstract][Full Text] [Related]
40. Molecular insights into the critical role of gallate moiety of green tea catechins in modulating prion fibrillation, cellular internalization, and neuronal toxicity.
Admane N; Srivastava A; Jamal S; Sharma R; Kundu B; Grover A
Int J Biol Macromol; 2022 Dec; 223(Pt A):755-765. PubMed ID: 36368361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
